Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
$0.01
+7.0%
$0.01
$0.00
$0.70
$255K0.7986,671 shs6,541 shs
Evogene Ltd. stock logo
EVGN
Evogene
$0.58
-1.2%
$0.74
$0.52
$1.63
$5.15M1.351.44 million shs126,770 shs
Senestech, Inc. stock logo
SNES
Senestech
$1.65
-2.4%
$1.64
$1.41
$6.24
$8.96M0.2847,816 shs26,131 shs
Trinseo PLC stock logo
TSE
Trinseo
$0.23
$0.22
$0.23
$4.42
$8.10M1.46581,198 shsN/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
-65.45%+5,600.00%+1,800.00%-84.59%-99.06%
Evogene Ltd. stock logo
EVGN
Evogene
-0.17%-3.07%-22.34%-25.88%-67.35%
Senestech, Inc. stock logo
SNES
Senestech
-1.74%+2.42%+1.81%-11.98%-41.72%
Trinseo PLC stock logo
TSE
Trinseo
0.00%0.00%0.00%0.00%-93.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
$0.01
+7.0%
$0.01
$0.00
$0.70
$255K0.7986,671 shs6,541 shs
Evogene Ltd. stock logo
EVGN
Evogene
$0.58
-1.2%
$0.74
$0.52
$1.63
$5.15M1.351.44 million shs126,770 shs
Senestech, Inc. stock logo
SNES
Senestech
$1.65
-2.4%
$1.64
$1.41
$6.24
$8.96M0.2847,816 shs26,131 shs
Trinseo PLC stock logo
TSE
Trinseo
$0.23
$0.22
$0.23
$4.42
$8.10M1.46581,198 shsN/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
-65.45%+5,600.00%+1,800.00%-84.59%-99.06%
Evogene Ltd. stock logo
EVGN
Evogene
-0.17%-3.07%-22.34%-25.88%-67.35%
Senestech, Inc. stock logo
SNES
Senestech
-1.74%+2.42%+1.81%-11.98%-41.72%
Trinseo PLC stock logo
TSE
Trinseo
0.00%0.00%0.00%0.00%-93.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
2.67
Moderate Buy$1.0016,293.44% Upside
Evogene Ltd. stock logo
EVGN
Evogene
2.50
Moderate BuyN/AN/A
Senestech, Inc. stock logo
SNES
Senestech
2.33
HoldN/AN/A
Trinseo PLC stock logo
TSE
Trinseo
1.67
Reduce$1.00334.78% Upside

Current Analyst Ratings Breakdown

Latest EVGN, CARM, SNES, and TSE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/27/2026
Senestech, Inc. stock logo
SNES
Senestech
Reiterated RatingSell (E+)
(Data available from 6/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
$10.77M0.02N/AN/A($0.67) per share-0.01
Evogene Ltd. stock logo
EVGN
Evogene
$3.85M1.29N/AN/A$1.37 per share0.42
Senestech, Inc. stock logo
SNES
Senestech
$2.22M4.05N/AN/A$1.83 per share0.93
Trinseo PLC stock logo
TSE
Trinseo
$3.13B0.00N/AN/A($17.51) per share-0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
-$60.48M$0.730.01N/AN/A-254.28%N/A-192.17%N/A
Evogene Ltd. stock logo
EVGN
Evogene
-$8.48M-$1.39N/AN/AN/A-638.12%-158.82%-80.37%8/26/2026 (Estimated)
Senestech, Inc. stock logo
SNES
Senestech
-$6.38M-$1.89N/AN/AN/A-304.22%-67.60%-49.21%8/6/2026 (Estimated)
Trinseo PLC stock logo
TSE
Trinseo
-$348.50M-$11.55N/AN/AN/A-13.15%N/A-11.72%N/A

Latest EVGN, CARM, SNES, and TSE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/16/2026Q1 2026
Evogene Ltd. stock logo
EVGN
Evogene
-$0.27-$0.60-$0.33-$0.60$0.35 million$0.33 million
5/12/2026Q1 2026
Senestech, Inc. stock logo
SNES
Senestech
-$0.33-$0.31+$0.02-$0.39$0.63 million$0.49 million
3/12/2026Q4 2025
Senestech, Inc. stock logo
SNES
Senestech
-$0.30-$0.29+$0.01-$0.35$0.78 million$0.42 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
N/AN/AN/AN/AN/A
Evogene Ltd. stock logo
EVGN
Evogene
N/AN/AN/AN/AN/A
Senestech, Inc. stock logo
SNES
Senestech
N/AN/AN/AN/AN/A
Trinseo PLC stock logo
TSE
Trinseo
$0.0417.39%-52.18%N/A 1 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
N/A
0.48
0.48
Evogene Ltd. stock logo
EVGN
Evogene
N/A
2.79
2.76
Senestech, Inc. stock logo
SNES
Senestech
0.02
8.91
7.79
Trinseo PLC stock logo
TSE
Trinseo
N/A
1.37
0.85

Institutional Ownership

CompanyInstitutional Ownership
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
44.27%
Evogene Ltd. stock logo
EVGN
Evogene
10.40%
Senestech, Inc. stock logo
SNES
Senestech
5.19%
Trinseo PLC stock logo
TSE
Trinseo
82.69%

Insider Ownership

CompanyInsider Ownership
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
6.90%
Evogene Ltd. stock logo
EVGN
Evogene
7.40%
Senestech, Inc. stock logo
SNES
Senestech
2.20%
Trinseo PLC stock logo
TSE
Trinseo
4.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Carisma Therapeutics Inc. stock logo
CARM
Carisma Therapeutics
2041.85 million38.91 millionNo Data
Evogene Ltd. stock logo
EVGN
Evogene
1408.72 million8.07 millionNo Data
Senestech, Inc. stock logo
SNES
Senestech
305.30 million5.19 millionNot Optionable
Trinseo PLC stock logo
TSE
Trinseo
2,95035.20 million33.62 millionOptionable

Recent News About These Companies

Trinseo Reports First Quarter 2026 Financial Results
New Strong Sell Stocks for January 30th
Insider Traders Lose US$208k As Trinseo Drops
Trinseo Faces NYSE Non-Compliance Notice
Alembic Global Downgrades Trinseo (TSE)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Carisma Therapeutics stock logo

Carisma Therapeutics NASDAQ:CARM

$0.0061 +0.00 (+7.02%)
As of 02:10 PM Eastern

Carisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. The company's ex vivo CAR-M cell therapies include CT-0508, a CAR-macrophage, which is in Phase 1 clinical trial to treat solid tumors; CT-0525, a CAR-monocyte that is in Phase 1 clinical trial to treat solid tumors; and CT-1119, a mesothelin-targeted CAR-Monocyte that is in pre-clinical stage to treat patients with advanced mesothelin-positive solid tumors, including lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and others. It is also developing in vivo CAR-M cell therapies in collaboration with Moderna Therapeutics to address multiple cancer targets; and multiple assets for the potential treatment of diseases beyond oncology, including fibrosis and other immunologic and inflammatory diseases. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Evogene stock logo

Evogene NASDAQ:EVGN

$0.58 -0.01 (-1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$0.56 -0.02 (-3.41%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Senestech stock logo

Senestech NASDAQ:SNES

$1.65 -0.04 (-2.37%)
Closing price 04:00 PM Eastern
Extended Trading
$1.64 -0.01 (-0.61%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Trinseo stock logo

Trinseo NYSE:TSE

$0.23 0.00 (0.00%)
As of 06/11/2026

Trinseo PLC operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally. It operates through five segments: Engineered Materials, Latex Binders, Plastics Solutions, Polystyrene, and Americas Styrenics. The Engineered Materials segment offers rigid thermoplastic compounds and blends, soft thermoplastic, continuous cast, cell cast, activated methyl methacrylates (MMA), PMMA resins, and extruded PMMA sheets and resins for consumer electronics, medical, footwear, automotive, and building and construction applications under the EMERGE, CALIBRE, PLEXIGLAS, ALTUGLAS, ACRYSPA, AVONITE, STUDIO, MEGOL, APILON, APIGO, and APINAT brands. The Latex Binders segment provides styrene-butadiene latex, and other latex polymers and binders primarily for coated paper and packaging board, carpet, and artificial turf backings, as well as the adhesive, building and construction, and technical textile paper market. The Plastics Solutions segment offers acrylonitrile-butadiene-styrene, styrene-acrylonitrile, polycarbonate, and compounds and blends for automotive and other applications under the MAGNUM brand. The Polystyrene segment provides general purpose polystyrenes and high impact polystyrene for use in appliances, food packaging and food service disposables, consumer electronics, and building and construction materials under the STYRON brand. The Americas Styrenics segment provides styrene and polystyrene for appliances, food packaging, food service disposables, consumer electronics, and building and construction materials applications. Trinseo PLC was incorporated in 2015 and is headquartered in Wayne, Pennsylvania.